In this medical video learn how a new drug, which is under study means fewer attacks, fewer lesions, and a slower progression of disability for multiple sclerosis patients.
Read the full transcript »
Jennifer Mathews: Art Coscuna likes competition. Art Coscuna: I was at high school quarterback, All-State, played baseball, football, soccer. Jennifer Mathews: Then, some competition he didn't see coming -- Multiple Sclerosis. Art Coscuna: My whole left side, every muscle, contracted. It tightened up at once, and I fell right to the ground. Jennifer Mathews: That first attack was three years ago. Cheryl Hillman has been living with MS for 23 years. Cheryl Hillman: I always have problems with my left side, and my legs are predominately affected, so walking becomes a problem. Jennifer Mathews: MS patients like Cheryl and Art take medications that help them stay well, but researchers like neurologist Ben Thrower are looking for ways to stop the disease. He may have found one. Ben Thrower: Rather than letting them develop into an aggressive, or attacking, sort of white blood cell, it will send them down the pathway to being a more regulatory, more protective type of white blood cell. Jennifer Mathews: Doctor Thrower says this means fewer attacks, fewer lesions, and slower progression of disability. Ben Thrower: In the initial trials, what we've seen is that the drug appears to suppress the inflammatory activity on MRI. Jennifer Mathews: For now, Art's therapy is to keep active. Art Coscuna: My coordination might not be where it was at, but I can still do anything and everything. Jennifer Mathews: Cheryl stays active in water. Cheryl Hillman: You can exercise the muscles without doing a lot of jolting to your body, without working up a sweat. Jennifer Mathews: Exercise keeps them going, while Cheryl and Art wait for a drug to keep them well. This is Jennifer Mathews reporting.
Copyright © 2005 - 2014 Healthline Networks, Inc. All rights reserved for Healthline.